On the public citation graph
Therapeutic monoclonal antibodies
0 signed · 368 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/1529-0131(199809)41:9<1552::aid-art5>3.0.co;2-wopenalex-snapshot
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
inferredcites →https://doi.org/10.1002/art.1780390107openalex-snapshot
Percentage of anti‐CD4 monoclonal antibody‐coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens
inferredcites →https://doi.org/10.1016/s0065-2776(08)60891-3openalex-snapshot
Anti-Tumor Necrosis Factor-α Therapy of Rheumatoid Arthritis
inferredcites →https://doi.org/10.1016/s0140-6736(94)90007-8openalex-snapshot
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
inferredcites →https://doi.org/10.1016/s0140-6736(94)90628-9openalex-snapshot
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
inferredcites →https://doi.org/10.1016/s0140-6736(96)10452-9openalex-snapshot
Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study
inferredcites →https://doi.org/10.1016/s0140-6736(97)09278-7openalex-snapshot
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients
inferredcites →https://doi.org/10.1016/s0140-6736(99)05246-0openalex-snapshot
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
inferredcites →https://doi.org/10.1016/s0923-2494(98)80001-1openalex-snapshot
In vivo and In vitro production of monoclonal antibodies: Current possibilities and future perspectives
inferredcites →https://doi.org/10.1038/256495a0openalex-snapshot
Continuous cultures of fused cells secreting antibody of predefined specificity
inferredcites →https://doi.org/10.1056/nejm198508083130601openalex-snapshot
A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal Transplants
inferredcites →https://doi.org/10.1056/nejm199706123362401openalex-snapshot
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
inferredcites →https://doi.org/10.1056/nejm199710093371502openalex-snapshot
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
inferredcites →https://doi.org/10.1056/nejm199905063401804openalex-snapshot
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
inferredcites →https://doi.org/10.1056/nejm199905273402103openalex-snapshot
Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T Levels
inferredcites →https://doi.org/10.1086/314523openalex-snapshot
Reduction of Respiratory Syncytial Virus (RSV) in Tracheal Aspirates in Intubated Infants by Use of Humanized Monoclonal Antibody to RSV F Protein
inferredcites →https://doi.org/10.1097/00007890-199701150-00007openalex-snapshot
A PHASE I TRIAL OF HUMANIZED ANTI-INTERLEUKIN 2 RECEPTOR ANTIBODY IN RENAL TRANSPLANTATION1
inferredcites →https://doi.org/10.1097/00007890-199901150-00019openalex-snapshot
REDUCTION OF ACUTE RENAL ALLOGRAFT REJECTION BY DACLIZUMAB1
inferredcites →https://doi.org/10.1097/00007890-199901270-00011openalex-snapshot
IN VIVO GENERATION OF C4d, Bb, iC3b, AND SC5b-9 AFTER OKT3 ADMINISTRATION IN KIDNEY AND LUNG TRANSPLANT RECIPIENTS1,2
inferredcites →https://doi.org/10.1097/00007890-199901270-00016openalex-snapshot
REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2
inferredcites →https://doi.org/10.1136/gut.40.4.443openalex-snapshot
Tumour necrosis factor and Crohn's disease.
inferredcites →https://doi.org/10.1146/annurev.immunol.16.1.619openalex-snapshot
HOW DO MONOCLONAL ANTIBODIES INDUCE TOLERANCE? A Role for Infectious Tolerance?
inferredcites →https://doi.org/10.1200/jco.1996.14.3.737openalex-snapshot
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.
inferredcites →https://doi.org/10.1200/jco.1998.16.8.2825openalex-snapshot
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
inferredcites →https://doi.org/10.1200/jco.1999.17.1.268openalex-snapshot
Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy
inferredcites →https://doi.org/10.1542/peds.102.3.531openalex-snapshot
Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants
inferredcites →https://doi.org/10.4049/jimmunol.148.11.3461openalex-snapshot
Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4524769openalex-extracted
Screening High Affinity Monoclonal Antibody Producing Hybridomas Using a Graphene Oxide-Based Fluorescence Biosensor
inferred← citeshttps://doi.org/10.2139/ssrn.4640091openalex-extracted
Screening High Affinity Monoclonal Antibody Producing Hybridomas Using a Graphene Oxide-Based Fluorescence Biosensor
inferred← citeshttps://doi.org/10.1002/0470867949.ch16openalex-snapshot
Monoclonal Antibodies: The Generation and Application of ‘Tools of the Trade’ Within Biomedical Science
inferred← citeshttps://doi.org/10.1002/0471266949.bmc029.pub2openalex-snapshot
Receptor Targets in Drug Discovery
inferred← citeshttps://doi.org/10.1002/1521-4141(2002010)32:10<2773::aid-immu2773>3.0.co;2-gopenalex-snapshot
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies
inferred← citeshttps://doi.org/10.1002/9781118846193.ch33openalex-snapshot
History of monoclonal antibodies and lessons for the development of stem cell therapeutics
inferred← citeshttps://doi.org/10.1002/9781118873922.ch23openalex-snapshot
Nonclinical Safety Assessment of Biotechnology‐Derived Products: Considerations and Challenges
inferred← citeshttps://doi.org/10.1002/9781119769620.ch2openalex-snapshot
Natural Polymer Types and Applications
inferred← citeshttps://doi.org/10.1002/9783527620982.chopenalex-snapshot
Current Status of Biopharmaceuticals: Approved Products and Trends in Approvals
inferred← citeshttps://doi.org/10.1002/bit.10790openalex-snapshot
High‐level expression of full‐length antibodies using trans‐complementing expression vectors
inferred← citeshttps://doi.org/10.1002/bit.25286openalex-snapshot
CHOPPI: A web tool for the analysis of immunogenicity risk from host cell proteins in CHO‐based protein production
inferred← citeshttps://doi.org/10.1002/bit.25457openalex-snapshot
On the model‐based optimization of secreting mammalian cell (GS‐NS0) cultures
inferred← citeshttps://doi.org/10.1002/btm2.70121openalex-snapshot
Current GMP standards for the large‐scale production of monoclonal antibodies
inferred← citeshttps://doi.org/10.1002/ctm2.70400openalex-snapshot
CD70: An emerging target for integrated cancer diagnosis and therapy
inferred← citeshttps://doi.org/10.1002/elps.201900195openalex-snapshot
Analysis of four therapeutic monoclonal antibodies by online capillary isoelectric focusing directly coupled to quadrupole time‐of‐flight mass spectrometry
inferred← citeshttps://doi.org/10.1002/elps.202000076openalex-snapshot
Dynamic pH barrage junction focusing of amino acids, peptides, and digested monoclonal antibodies in capillary electrophoresis–mass spectrometry
inferred← citeshttps://doi.org/10.1002/jbio.202200252openalex-snapshot
Reflective FT‐NIR and SERS studies of HER‐II breast cancer biomarker using plasmonic‐active nanostructured thin film immobilized oriented antibody
inferred← citeshttps://doi.org/10.1002/jcp.22146openalex-snapshot
Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivation
inferred← citeshttps://doi.org/10.1002/jcph.339openalex-snapshot
Biosimilar monoclonal antibodies: A Canadian regulatory perspective on the assessment of clinically relevant differences and indication extrapolation
inferred← citeshttps://doi.org/10.1002/jcph.374openalex-snapshot
Pharmacokinetics of anti‐TNF monoclonal antibodies in inflammatory bowel disease: Adding value to current practice
inferred← citeshttps://doi.org/10.1002/jmv.20077openalex-snapshot
Transgenic tobacco cells producing the human monoclonal antibody to hepatitis B virus surface antigen
inferred← citeshttps://doi.org/10.1002/jps.21682openalex-snapshot
Pharmacokinetic Allometric Scaling of Antibodies: Application to the First-In-Human Dose Estimation
inferred← citeshttps://doi.org/10.1002/jssc.201200199openalex-snapshot
Purification of polyclonal antibodies from C ohn fraction II + III, skim milk, and whey by affinity chromatography using a hexamer peptide ligand
inferred← citeshttps://doi.org/10.1002/jssc.202200112openalex-snapshot
Approaches for the detection and analysis of antidrug antibodies to biopharmaceuticals: A review
inferred← citeshttps://doi.org/10.1002/mabi.201200478openalex-snapshot
Poly(Lactide-co -Glycolide) Nanoparticles, Layer by Layer Engineered for the Sustainable Delivery of AntiTNF-α
inferred← citeshttps://doi.org/10.1002/pmic.200500409openalex-snapshot
Proteomics‐based generation and characterization of monoclonal antibodies against human liver mitochondrial proteins
inferred← citeshttps://doi.org/10.1002/prot.24595openalex-snapshot
Automated Aufbau of antibody structures from given sequences using Macromoltek's SmrtMolAntibody
inferred← citeshttps://doi.org/10.1002/prp2.535openalex-snapshot
The pharmacology and therapeutic applications of monoclonal antibodies
inferred← citeshttps://doi.org/10.1002/rcm.3330openalex-snapshot
Determination of N‐glycosylation sites and site heterogeneity in a monoclonal antibody by electrospray quadrupole ion‐mobility time‐of‐flight mass spectrometry
inferred← citeshttps://doi.org/10.1006/pupt.2002.0371openalex-snapshot
What's in the Pipeline? Prospects for Monoclonal Antibodies (mAbs) as Therapies for Lung Diseases
inferred← citeshttps://doi.org/10.1007/10_2019_116openalex-snapshot
Therapeutic Antibody Engineering and Selection Strategies
inferred← citeshttps://doi.org/10.1007/978-1-4020-5889-9_24openalex-snapshot
T-cell modulating antibodies in inflammatory bowel disease
inferred← citeshttps://doi.org/10.1007/978-1-4419-8877-5_2openalex-snapshot
Generation, Engineering and Production of Human Antibodies Using Hucal®
inferred← citeshttps://doi.org/10.1007/978-1-4613-1095-2_22openalex-snapshot
The Role of Anti-IgE in Asthma
inferred← citeshttps://doi.org/10.1007/978-1-4615-1447-3_12openalex-snapshot
Immunosuppressive Therapy
inferred← citeshttps://doi.org/10.1007/978-1-59259-167-1_8openalex-snapshot
The Use of Drug-Monoclonal Antibody Conjugates for the Treatment of Cancer
inferred← citeshttps://doi.org/10.1007/978-1-60327-297-1_45openalex-snapshot
Asthma and Allergic Diseases
inferred← citeshttps://doi.org/10.1007/978-3-030-92938-1_1openalex-snapshot
Introduction to Biologic Therapy for Psoriasis
inferred← citeshttps://doi.org/10.1007/978-3-319-72077-7_3openalex-snapshot
Naïve Human Antibody Libraries for Infectious Diseases
inferred← citeshttps://doi.org/10.1007/978-3-642-18081-1_50openalex-snapshot
The Role of IgM- and IgA-enriched Immunoglobulins in the Treatment of Sepsis and Septic Shock
inferred← citeshttps://doi.org/10.1007/978-3-642-56437-6_12openalex-snapshot
Neue immunmodulierende Strategien in der Dermatologie
inferred← citeshttps://doi.org/10.1007/978-3-662-60410-6_17openalex-snapshot
Biologika in der pädiatrischen Rheumatologie
inferred← citeshttps://doi.org/10.1007/978-88-470-2014-6_20openalex-snapshot
Immunoglobulins in Sepsis
inferred← citeshttps://doi.org/10.1007/978-90-481-2289-9_4openalex-snapshot
Recombinant proteins and genomics in cancer therapy
inferred← citeshttps://doi.org/10.1007/978-981-15-7586-0_11openalex-snapshot
Designing Personalized and Innovative Novel Drug Therapies for Cancer Treatment
inferred← citeshttps://doi.org/10.1007/978-981-95-0221-9_11openalex-snapshot
Using Freeze-Drying to Stabilize Formulations of Monoclonal Antibodies
inferred← citeshttps://doi.org/10.1007/978-981-99-2196-6_23-1openalex-snapshot
Emerging Pathophysiology and Treatment of Prostate Cancer: Future Perspective
inferred← citeshttps://doi.org/10.1007/978-981-99-6263-1_23openalex-snapshot
Emerging Pathophysiology and Treatment of Prostate Cancer: Future Perspective
inferred← citeshttps://doi.org/10.1007/s00216-016-9708-4openalex-snapshot
High-throughput identification of monoclonal antibodies after compounding by UV spectroscopy coupled to chemometrics analysis
inferred← citeshttps://doi.org/10.1007/s00415-012-6590-7openalex-snapshot
Targeted immunotherapy trials for idiopathic inflammatory myopathies
inferred← citeshttps://doi.org/10.1007/s00761-007-1190-3openalex-snapshot
Antikörpertherapie in klinischer und präklinischer Anwendung bei gastrointestinalen Karzinomen
inferred← citeshttps://doi.org/10.1007/s10517-012-1852-zopenalex-snapshot
Treatment of Experimental Ulcerative Colitis
inferred← citeshttps://doi.org/10.1007/s10517-013-2297-8openalex-snapshot
Cell Therapy of Refractory Crohn’s Disease
inferred← citeshttps://doi.org/10.1007/s11095-024-03684-4openalex-snapshot
Identification of Surfactant Impact on a Monoclonal Antibody Characterization via HPLC-Separation Based and Biophysical Methods
inferred← citeshttps://doi.org/10.1007/s11095-026-04160-xopenalex-snapshot
Electrostatic Interactions Guide the Detrimental Effect of Oleic Acid on Monoclonal Antibody Stability
inferred← citeshttps://doi.org/10.1007/s11910-017-0785-3openalex-snapshot
Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology
inferred← citeshttps://doi.org/10.1007/s12010-009-8657-1openalex-snapshot
Generation of a Recombinant Full-Length Human Antibody Binding to Botulinum Neurotoxin A
inferred← citeshttps://doi.org/10.1007/s12033-026-01595-wopenalex-snapshot
Applications of Recombinant DNA Technology in Medicine: A Comprehensive Review
inferred← citeshttps://doi.org/10.1007/s12257-011-0196-2openalex-snapshot
Production of a monoclonal antibody by ascites, hollow fiber system, and transgenic plants for vaccine production using CB.Hep-1 mAb as a study case
inferred← citeshttps://doi.org/10.1007/s12257-024-00104-7openalex-snapshot
Study on the S239D/I332E mutation effect on the kinetics of Fc–Fc receptor binding through transition complex theory
inferred← citeshttps://doi.org/10.1007/s13181-023-00931-9openalex-snapshot
COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics)
inferred← citeshttps://doi.org/10.1007/s13277-012-0563-4openalex-snapshot
Development and validation of H11B2C2 monoclonal antibody-reactive hyaluronic acid binding protein: overexpression of HABP during human tumor progression
inferred← citeshttps://doi.org/10.1007/s40259-015-0135-4openalex-snapshot
Cost Effectiveness of Monoclonal Antibody Therapy for Rare Diseases: A Systematic Review
inferred← citeshttps://doi.org/10.1007/s40262-012-0027-4openalex-snapshot
Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies
inferred← citeshttps://doi.org/10.1007/s40262-015-0296-9openalex-snapshot
Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis
inferred← citeshttps://doi.org/10.1007/s40262-016-0450-zopenalex-snapshot
Genotypes Affecting the Pharmacokinetics of Anticancer Drugs
inferred← citeshttps://doi.org/10.1007/s40262-018-0680-3openalex-snapshot
Influence of Antigen Mass on the Pharmacokinetics of Therapeutic Antibodies in Humans
inferred← citeshttps://doi.org/10.1007/s44163-026-02485-5openalex-snapshot
ARTEMIS enables reusable analytical context generation from scientific literature
inferred← citeshttps://doi.org/10.1016/b978-0-12-801401-1.00007-4openalex-snapshot
Identifying and Reducing Potentially Wrong Immunoassay Results Even When Plausible and “Not-Unreasonable”
inferred← citeshttps://doi.org/10.1016/b978-0-12-804659-3.00016-6openalex-snapshot
Engineering Monoclonal Antibodies
inferred← citeshttps://doi.org/10.1016/b978-0-12-804659-3.00019-1openalex-snapshot
Medical Biotechnology
inferred← citeshttps://doi.org/10.1016/b978-0-12-819475-1.00011-0openalex-snapshot
Chemo-Enzymatic Syntheses of Oligosaccharides and Glycoconjugates
inferred← citeshttps://doi.org/10.1016/b978-0-323-82763-8.00258-2openalex-snapshot
Immunomodulating Agents
inferred← citeshttps://doi.org/10.1016/b978-0-323-95116-6.00002-5openalex-snapshot
Precision medicine: Dose for anticancer therapy
inferred← citeshttps://doi.org/10.1016/b978-0-323-96018-2.00118-8openalex-snapshot
Small molecules and food allergy
inferred← citeshttps://doi.org/10.1016/b978-0-323-99111-7.00013-1openalex-snapshot
Conventional treatment and new drugs
inferred← citeshttps://doi.org/10.1016/b978-0-443-06911-6.50019-0openalex-snapshot
Anti-inflammatory and immunosuppressant drugs
inferred← citeshttps://doi.org/10.1016/b978-0-443-19135-0.00003-3openalex-snapshot
Modern concepts of pharmaceutical biotechnology in drug development
inferred← citeshttps://doi.org/10.1016/b978-0-443-22264-1.00001-3openalex-snapshot
An overview of medicinal biotechnology: A historical perspective
inferred← citeshttps://doi.org/10.1016/b978-0-443-31592-3.00008-xopenalex-snapshot
Pharmacokinetics and pharmacodynamics in cancer pharmacology
inferred← citeshttps://doi.org/10.1016/b978-0-444-53267-1.50007-1openalex-snapshot
MONOCLONAL ANTIBODIES
inferred← citeshttps://doi.org/10.1016/b978-0-444-53273-2.50007-9openalex-snapshot
GLUCOCORTICOIDS AND DISEASE – MODIFYING ANTIRHEUMATIC DRUGS
inferred← citeshttps://doi.org/10.1016/b978-0-444-53717-1.01104-5openalex-snapshot
Monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/b978-0-7020-3471-8.00026-3openalex-snapshot
Anti-inflammatory and immunosuppressant drugs
inferred← citeshttps://doi.org/10.1016/b978-1-4160-3343-1.50024-4openalex-snapshot
Antibodies and Fusion Proteins
inferred← citeshttps://doi.org/10.1016/b978-1-4160-4044-6.50259-4openalex-snapshot
IMMUNOMODULATING AGENTS
inferred← citeshttps://doi.org/10.1016/b978-3-437-42523-3.00001-4openalex-snapshot
Allgemeine Pharmakologie und Toxikologie
inferred← citeshttps://doi.org/10.1016/j.addr.2026.115812openalex-snapshot
Challenges and developments in the manufacturing of high-concentration biotherapeutic monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/j.autrev.2013.08.005openalex-snapshot
A review on the association between inflammatory myopathies and vaccination
inferred← citeshttps://doi.org/10.1016/j.bioana.2023.12.003openalex-snapshot
Electrochemical aptamer-based biosensing of glycan-conjugated targets
inferred← citeshttps://doi.org/10.1016/j.biologicals.2008.07.002openalex-snapshot
Preparation and use of therapeutic antibodies primarily of human origin
inferred← citeshttps://doi.org/10.1016/j.bioorg.2025.108442openalex-snapshot
Small molecule therapeutics for receptor-mediated targeting through liposomes in breast cancer treatment: A comprehensive review
inferred← citeshttps://doi.org/10.1016/j.clinthera.2023.10.016openalex-snapshot
Clinically Approved Monoclonal Antibodies–based Immunotherapy: Association With Glycemic Control and Impact Role of Clinical Pharmacist for Cancer Patient Care
inferred← citeshttps://doi.org/10.1016/j.cyto.2021.155541openalex-snapshot
Effect of curcumin on proinflammatory cytokines: A meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1016/j.dld.2012.05.021openalex-snapshot
Adalimumab in ulcerative colitis: Ready for prime time
inferred← citeshttps://doi.org/10.1016/j.drup.2026.101447openalex-snapshot
Immunotherapy in cancer: Mechanisms and strategies to overcome resistance
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112753openalex-snapshot
Factor XII/XIIa inhibitors: Their discovery, development, and potential indications
inferred← citeshttps://doi.org/10.1016/j.ejogrb.2022.09.021openalex-snapshot
Effects of curcumin-piperine supplementation on systemic immunity in young women with premenstrual syndrome and dysmenorrhea: A randomized clinical trial
inferred← citeshttps://doi.org/10.1016/j.ejpb.2004.03.012openalex-snapshot
Second-generation biopharmaceuticals
inferred← citeshttps://doi.org/10.1016/j.ejpb.2024.114387openalex-snapshot
Light exacerbates local and global effects induced by pH unfolding of Ipilimumab
inferred← citeshttps://doi.org/10.1016/j.gastrohep.2009.07.003openalex-snapshot
Toxicidad hepática inducida por los nuevos fármacos inmunosupresores
inferred← citeshttps://doi.org/10.1016/j.giec.2006.08.016openalex-snapshot
Infusion Services in the Gastroenterology Practice
inferred← citeshttps://doi.org/10.1016/j.gtc.2004.02.014openalex-snapshot
Treatment of luminal and fistulizing Crohn's disease with infliximab
inferred← citeshttps://doi.org/10.1016/j.gtc.2006.09.002openalex-snapshot
Infliximab in Ulcerative Colitis
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e37634openalex-snapshot
Exploring recent progress of molecular farming for therapeutic and recombinant molecules in plant systems
inferred← citeshttps://doi.org/10.1016/j.hoc.2019.05.007openalex-snapshot
Impact of Novel Monoclonal Antibody Therapeutics on Blood Bank Pretransfusion Testing
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2018.07.120openalex-snapshot
Quantitation of the monoclonal antibody Denosumab by bioassay and validated LC methods
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.136747openalex-snapshot
Identification of a novel conserved B-cell epitope in p15 of the African swine fever virus
inferred← citeshttps://doi.org/10.1016/j.ijporl.2019.109674openalex-snapshot
Anti-IgE treatment in allergic rhinitis
inferred← citeshttps://doi.org/10.1016/j.imbio.2005.02.002openalex-snapshot
Generation of anti-Neu-glycolyl-ganglioside antibodies by immunization with an anti-idiotype monoclonal antibody: A self versus non-self-matter
inferred← citeshttps://doi.org/10.1016/j.imbio.2006.08.005openalex-snapshot
Insights into the immunogenetic basis of two ganglioside-associated idiotypic networks
inferred← citeshttps://doi.org/10.1016/j.imbio.2009.06.005openalex-snapshot
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case
inferred← citeshttps://doi.org/10.1016/j.intimp.2014.09.017openalex-snapshot
Mammalian cell display technology coupling with AID induced SHM in vitro: An ideal approach to the production of therapeutic antibodies
inferred← citeshttps://doi.org/10.1016/j.jbi.2023.104325openalex-snapshot
Integrating a new knowledge organisation system for monoclonal antibodies for therapeutic use authorised in Europe into HeTOP terminology-ontology server
inferred← citeshttps://doi.org/10.1016/j.jbiosc.2009.07.001openalex-snapshot
In vitro generation of anti-hepatitis B monoclonal antibodies from a single plasma cell using single-cell RT-PCR and cell-free protein synthesis
inferred← citeshttps://doi.org/10.1016/j.jbiosc.2010.01.013openalex-snapshot
Characterization of N-glycan structures and biofunction of anti-colorectal cancer monoclonal antibody CO17-1A produced in baculovirus-insect cell expression system
inferred← citeshttps://doi.org/10.1016/j.jchromb.2009.03.010openalex-snapshot
Affinity ligands for immunoglobulins based on the multicomponent Ugi reaction
inferred← citeshttps://doi.org/10.1016/j.jconrel.2003.12.013openalex-snapshot
Rational design of solid aerosols for immunoglobulin delivery by modulation of aerodynamic and release characteristics
inferred← citeshttps://doi.org/10.1016/j.jim.2013.08.011openalex-snapshot
An efficient detection agent for the high throughput screening of recombinant manufacturing cell lines
inferred← citeshttps://doi.org/10.1016/j.jmgm.2020.107774openalex-snapshot
Computational engineering the binding affinity of Adalimumab monoclonal antibody for designing potential biosimilar candidate
inferred← citeshttps://doi.org/10.1016/j.joen.2016.11.004openalex-snapshot
Prevalence of Apical Periodontitis in Patients with Inflammatory Bowel Diseases: A Retrospective Clinical Study
inferred← citeshttps://doi.org/10.1016/j.joen.2017.06.019openalex-snapshot
The Influence of Adalimumab on the Healing of Apical Periodontitis in Ferrets
inferred← citeshttps://doi.org/10.1016/j.joen.2018.09.004openalex-snapshot
Healing of Apical Periodontitis in Patients with Inflammatory Bowel Diseases and under Anti–tumor Necrosis Factor Alpha Therapy
inferred← citeshttps://doi.org/10.1016/j.jpba.2016.04.004openalex-snapshot
Hydrophobic interaction chromatography for the characterization of monoclonal antibodies and related products
inferred← citeshttps://doi.org/10.1016/j.medcle.2016.04.058openalex-snapshot
New agents for hypercholesterolemia
inferred← citeshttps://doi.org/10.1016/j.medcli.2015.01.016openalex-snapshot
Nuevos tratamientos para la hipercolesterolemia
inferred← citeshttps://doi.org/10.1016/j.phrs.2025.107901openalex-snapshot
Targeting of the IGFBP3/TMEM219 pathway restores intestinal stem cells capability of healing mucosa in gastrointestinal autoimmune disorders
inferred← citeshttps://doi.org/10.1016/j.reuma.2015.03.009openalex-snapshot
Documento de posicionamiento de la Sociedad Española de Reumatología sobre fármacos biosimilares
inferred← citeshttps://doi.org/10.1016/j.reumae.2015.03.012openalex-snapshot
Position Paper From the Spanish Society of Rheumatology on Biosimilar Drugs
inferred← citeshttps://doi.org/10.1016/j.sbi.2021.11.016openalex-snapshot
Sculpting therapeutic monoclonal antibody N-glycans using endoglycosidases
inferred← citeshttps://doi.org/10.1016/j.snb.2024.135575openalex-snapshot
Screening high affinity monoclonal antibody producing hybridomas using a graphene oxide-based fluorescence biosensor
inferred← citeshttps://doi.org/10.1016/j.talanta.2018.05.042openalex-snapshot
Simple and ultra-fast recognition and quantitation of compounded monoclonal antibodies: Application to flow injection analysis combined to UV spectroscopy and matching method
inferred← citeshttps://doi.org/10.1016/j.talanta.2024.127431openalex-snapshot
Biologically-driven RAFT polymerization-amplified platform for electrochemical detection of antibody drugs
inferred← citeshttps://doi.org/10.1016/j.tibtech.2005.07.005openalex-snapshot
Biopharmaceuticals: recent approvals and likely directions
inferred← citeshttps://doi.org/10.1016/j.tibtech.2010.05.001openalex-snapshot
Generating recombinant antibodies to the complete human proteome
inferred← citeshttps://doi.org/10.1016/j.trac.2025.118385openalex-snapshot
Characterization and quantification of therapeutic monoclonal antibodies, anti-drug antibodies and their interactions for clinical applications
inferred← citeshttps://doi.org/10.1016/j.virol.2012.01.038openalex-snapshot
A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis virus, Everglades virus and Mucambo virus when administered up to 48 h after airborne challenge
inferred← citeshttps://doi.org/10.1016/j.virusres.2020.198114openalex-snapshot
COVID-19 Vaccine: A comprehensive status report
inferred← citeshttps://doi.org/10.1016/s0003-2697(03)00469-xopenalex-snapshot
A proteomics-based approach for monoclonal antibody characterization
inferred← citeshttps://doi.org/10.1016/s0006-291x(02)00560-0openalex-snapshot
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase
inferred← citeshttps://doi.org/10.1016/s0022-1759(03)00206-0openalex-snapshot
Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals
inferred← citeshttps://doi.org/10.1016/s0025-7753(01)71871-4openalex-snapshot
Novedades terapéuticas del año 2000: los retos del médico y del gestor
inferred← citeshttps://doi.org/10.1016/s0090-4295(02)01504-2openalex-snapshot
Biotechnology and drug discovery—the future is here: a guide for the practicing urologist
inferred← citeshttps://doi.org/10.1016/s0140-6736(00)05256-9openalex-snapshot
How immunology is reshaping clinical disciplines: the example of haematology
inferred← citeshttps://doi.org/10.1016/s0140-6736(17)32814-3openalex-snapshot
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
inferred← citeshttps://doi.org/10.1016/s0167-5699(00)01667-4openalex-snapshot
Natural and designer binding sites made by phage display technology
inferred← citeshttps://doi.org/10.1016/s0378-6080(02)80044-7openalex-snapshot
Drugs acting on the immune system
inferred← citeshttps://doi.org/10.1016/s0378-6080(03)80044-2openalex-snapshot
Drugs acting on the immune system
inferred← citeshttps://doi.org/10.1016/s0749-0704(02)00028-3openalex-snapshot
New therapies: plasmapheresis, intravenous immunoglobulin, and monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/s0955-3886(00)00129-6openalex-snapshot
Current precision of immunological extracorporeal plasma treatment
inferred← citeshttps://doi.org/10.1016/s0959-440x(00)00108-1openalex-snapshot
Engineering therapeutic proteins
inferred← citeshttps://doi.org/10.1016/s1471-4892(01)00047-9openalex-snapshot
Monoclonal antibodies as a strategy for pulmonary diseases
inferred← citeshttps://doi.org/10.1016/s1570-0232(02)00712-2openalex-snapshot
Expanded bed adsorption processing of mammalian cell culture fluid: comparison with packed bed affinity chromatography
inferred← citeshttps://doi.org/10.1016/s1579-2129(06)60453-9openalex-snapshot
Anti-Immunoglobulin E, a Monoclonal Antibody to Treat Respiratory Disorders
inferred← citeshttps://doi.org/10.1021/bk-2013-1125.ch004openalex-snapshot
Utilizing mAb Adsorption Isotherms To Direct Process Development of a Strong Cation-Exchange Chromatography Step
inferred← citeshttps://doi.org/10.1021/cr000118yopenalex-snapshot
The Development of the α-Particle Emitting Radionuclides 212Bi and 213Bi, and Their Decay Chain Related Radionuclides, for Therapeutic Applications
inferred← citeshttps://doi.org/10.1021/jp505295jopenalex-snapshot
Kinetic Analysis of the Multistep Aggregation Mechanism of Monoclonal Antibodies
inferred← citeshttps://doi.org/10.1021/jp508000wopenalex-snapshot
Role of Cosolutes in the Aggregation Kinetics of Monoclonal Antibodies
inferred← citeshttps://doi.org/10.1023/a:1017921702775openalex-snapshot
CB.Hep-1 hybridoma growth and antibody production using protein-free medium in a hollow fiber bioreactor
inferred← citeshttps://doi.org/10.1038/aps.2012.91openalex-snapshot
N-Propionyl polysialic acid precursor enhances the susceptibility of multiple myeloma to antitumor effect of anti-NprPSA monoclonal antibody
inferred← citeshttps://doi.org/10.1038/clpt.2011.8openalex-snapshot
Immunoconjugates Against Solid Tumors: Mind the Gap
inferred← citeshttps://doi.org/10.1038/ncpneuro0016openalex-snapshot
Drug Insight: using monoclonal antibodies to treat multiple sclerosis
inferred← citeshttps://doi.org/10.1038/nrd1957openalex-snapshot
Antibody targeted drugs as cancer therapeutics
inferred← citeshttps://doi.org/10.1038/s41392-024-01952-8openalex-snapshot
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
inferred← citeshttps://doi.org/10.1038/s41525-022-00336-7openalex-snapshot
Medicine and health of 21st Century: Not just a high biotech-driven solution
inferred← citeshttps://doi.org/10.1038/sj.eye.6701669openalex-snapshot
Topically applied antibody fragments penetrate into the back of the rabbit eye
inferred← citeshttps://doi.org/10.1038/srep15766openalex-snapshot
Fluorescently-tagged anti-ganglioside antibody selectively identifies peripheral nerve in living animals
inferred← citeshttps://doi.org/10.1039/d1ay01556gopenalex-snapshot
An improved capillary isoelectric focusing-mass spectrometry method for high-resolution characterization of monoclonal antibody charge variants
inferred← citeshttps://doi.org/10.1039/d1cs01170gopenalex-snapshot
Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation
inferred← citeshttps://doi.org/10.1039/d2ay01567fopenalex-snapshot
Process integrated biosensors for real-time monitoring of antibodies for automated affinity purification
inferred← citeshttps://doi.org/10.1039/d3ay02114aopenalex-snapshot
Determination of [Glu 1 ]-fibrinopeptide B purity by gas chromatography – isotope dilution mass spectrometry
inferred← citeshttps://doi.org/10.1042/bcj20170342openalex-snapshot
IgG light chain-independent secretion of heavy chain dimers: consequence for therapeutic antibody production and design
inferred← citeshttps://doi.org/10.1046/j.0818-9641.2002.01145.xopenalex-snapshot
The potential of antibody‐based immunosuppressive agents for corneal transplantation
inferred← citeshttps://doi.org/10.1046/j.1365-2249.2002.01808.xopenalex-snapshot
Penetration of engineered antibody fragments into the eye
inferred← citeshttps://doi.org/10.1051/medsci/20042011999openalex-snapshot
Immunoprophylaxie des infections respiratoires
inferred← citeshttps://doi.org/10.1053/gast.2002.33426openalex-snapshot
Biologic therapy of inflammatory bowel disease
inferred← citeshttps://doi.org/10.1053/gast.2003.50145openalex-snapshot
Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial
inferred← citeshttps://doi.org/10.1053/sonu.2002.33070openalex-snapshot
Clinical issues in the administration of an anti-epidermal growth factor receptor monoclonal antibody, IMC-C225
inferred← citeshttps://doi.org/10.1056/nejmoa020888openalex-snapshot
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
inferred← citeshttps://doi.org/10.1080/00032710008543210openalex-snapshot
Applications and Recent Developments in the use of Antibodies for Analysis
inferred← citeshttps://doi.org/10.1080/02648725.2002.10648029openalex-snapshot
A Rational Design Approach for Developing Immunomodulators Based on CD4 and CD8
inferred← citeshttps://doi.org/10.1080/07853890802698842openalex-snapshot
Challenges in monoclonal antibody-based therapies
inferred← citeshttps://doi.org/10.1080/08982104.2021.1903035openalex-snapshot
Functionalized liposomes as drug nanocarriers for active targeted cancer therapy: a systematic review
inferred← citeshttps://doi.org/10.1080/08982104.2023.2268710openalex-snapshot
Recent advances in liposome-based targeted cancer therapy
inferred← citeshttps://doi.org/10.1080/1024533021000037180openalex-snapshot
The Evolving Role of Monoclonal Antibodies and Dendritic Cell Therapy in Hematologic Malignancies
inferred← citeshttps://doi.org/10.1080/10408347.2025.2472793openalex-snapshot
Anti-diabetic Biologicals: Exploring the Role of Different Analytical Techniques
inferred← citeshttps://doi.org/10.1080/1061186x.2023.2295803openalex-snapshot
A paradigm use of monoclonal antibodies-conjugated nanoparticles in breast cancer treatment: current status and potential approaches
inferred← citeshttps://doi.org/10.1080/14712598.2026.2664733openalex-snapshot
Monoclonal antibodies in the management of hereditary angioedema
inferred← citeshttps://doi.org/10.1080/17425255.2021.1982892openalex-snapshot
The impact of CGRPergic monoclonal antibodies on prophylactic antimigraine therapy and potential adverse events
inferred← citeshttps://doi.org/10.1080/19420862.2018.1525253openalex-snapshot
Comprehensive characterization of monoclonal antibody by Fourier transform ion cyclotron resonance mass spectrometry
inferred← citeshttps://doi.org/10.1080/2162402x.2019.1596004openalex-snapshot
Interaction of tumor-associated macrophages and cancer chemotherapy
inferred← citeshttps://doi.org/10.1086/505912openalex-snapshot
A Mouse Monoclonal Antibody against Epstein‐Barr Virus Envelope Glycoprotein 350 Prevents Infection Both In Vitro and In Vivo
inferred← citeshttps://doi.org/10.1089/153685903322538791openalex-snapshot
Recombinant Anti-Botulinum Neurotoxin A Single-Chain Variable Fragment Antibody Generated Using a Phage Display System
inferred← citeshttps://doi.org/10.1089/153685903322538836openalex-snapshot
Generation and Characterization of an Anti-Idiotype Monoclonal Antibody Related to GM3(NeuGc) Ganglioside
showing the first 200 of 341 · page through all 341
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.